IPO Issue Details
Issue Price / Price Band₹735 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size20 Shares per Lot
Total Issue Size1,18,24,163 shares (aggregating up to ₹869.08 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryFresh Capital-cum-Offer for Sale
Exchange / PlatformNSE & BSE
IPO TypeMainboard
Subscription OpenWed, 06 Sep 2023
Subscription CloseFri, 08 Sep 2023
Anchor AllotmentTue, 05 Sep 2023
Basis of AllotmentWed, 13 Sep 2023
Initiation of RefundsThu, 14 Sep 2023
Credit of Shares to DematFri, 15 Sep 2023
Listing DateMon, 18 Sep 2023
UPI Mandate Deadline2023-09-08
Application & Investment Details
Retail — Min (1 Lots)₹14,700 — 20 shares
Retail — Max (13 Lots)₹191,100 (13 Lots)
HNI — Min (14 Lots)₹2,05,800 — 280 shares
EPS (Pre-IPO)₹13.95
P/E Ratio (Pre-IPO)52.68x
P/E Ratio (Post-IPO)66.1x
Post-IPO Promoter Holding6,55,66,022 shares
Fresh Issue Shares73,74,163 shares (aggregating up to ₹542.00 Cr)
Offer for Sale Shares44,50,000 shares of ₹10 (aggregating up to ₹327.08 Cr)
About Jupiter Life Line Hospitals Ltd.
Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.Jupiter Life Line Hospitals has been operating as a corporate quaternary care healthcare service provider in the western regions of India and currently operates three hospitals under the "Jupiter" brand in Thane, Pune, and Indore, with a total operational bed capacity of 1194 beds, and 1,306 doctors including specialists, physicians, and surgeons, as of March 31, 2023. The company is currently developing a multi-specialty hospital in Dombivli, Maharashtra, which is designed to accommodate over 500 beds and has commenced construction in April 2023.According to the CRISIL Report, the company's Thane and Indore hospitals are amongst the few hospitals in the western region of India to provide neuro-rehabilitation services through a dedicated robotic and computer-assisted neuro-rehabilitation center. Additionally, it operates one of the few multi-organ transplant centers in Thane. All the hospitals in Thane, Pune, and Indore have been certified by the National Accreditation Board for Hospitals & Healthcare Providers (NABH) and have been accredited in the field of medical testing by the National Accreditation Board for Testing and Calibration Laboratories (NABL).The company's inpatient and outpatient revenue is diversified across hospitals with Thane, Pune, and Indore hospitals accounting for 54.18%, 34.03%, and 11.79%, respectively, of the revenue from operations in Fiscal 2023.
Objects of the Issue
Jupiter Life Line Hospitals Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
1 Repayment/pre-payment, in full or part, of borrowings availed from banks by the Company and Material Subsidiary;and
510.16
2
2 General corporate purposes
1.16
Shareholding & Lock-in
Pre-IPO Promoter Holding
Not Available
Post-IPO Promoter Holding
6,55,66,022 shares
Lock-in Period (30%)October 13, 2023
Lock-in Period (50%)December 12, 2023